These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 31779197)

  • 21. Potential gene therapy for lecithin-cholesterol acyltransferase (LCAT)-deficient and hypoalphalipoproteinemic patients with adenovirus-mediated transfer of human LCAT gene.
    Séguret-Macé S; Latta-Mahieu M; Castro G; Luc G; Fruchart JC; Rubin E; Denèfle P; Duverger N
    Circulation; 1996 Nov; 94(9):2177-84. PubMed ID: 8901669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Arg123-Tyr166 central domain of human ApoAI is critical for lecithin:cholesterol acyltransferase-induced hyperalphalipoproteinemia and HDL remodeling in transgenic mice.
    Holvoet P; De Geest B; Van Linthout S; Lox M; Danloy S; Raes K; Collen D
    Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):459-66. PubMed ID: 10669644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant human LCAT normalizes plasma lipoprotein profile in LCAT deficiency.
    Simonelli S; Tinti C; Salvini L; Tinti L; Ossoli A; Vitali C; Sousa V; Orsini G; Nolli ML; Franceschini G; Calabresi L
    Biologicals; 2013 Nov; 41(6):446-9. PubMed ID: 24140107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of human lecithin-cholesterol acyltransferase in transgenic mice. Effect of human apolipoprotein AI and human apolipoprotein all on plasma lipoprotein cholesterol metabolism.
    Francone OL; Gong EL; Ng DS; Fielding CJ; Rubin EM
    J Clin Invest; 1995 Sep; 96(3):1440-8. PubMed ID: 7657816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of probucol in lecithin-cholesterol acyltransferase-deficient mice: inhibition of 2 independent cellular cholesterol-releasing pathways in vivo.
    Tomimoto S; Tsujita M; Okazaki M; Usui S; Tada T; Fukutomi T; Ito S; Itoh M; Yokoyama S
    Arterioscler Thromb Vasc Biol; 2001 Mar; 21(3):394-400. PubMed ID: 11231919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence against alterations in Lecithin:cholesterol acyltransferase (LCAT) activity in familial combined hyperlipidemia.
    Ribalta J; La Ville AE; Vallvé JC; Girona J; Masana L
    Atherosclerosis; 1998 Jun; 138(2):383-9. PubMed ID: 9690923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipid oxidation in carriers of lecithin:cholesterol acyltransferase gene mutations.
    Holleboom AG; Daniil G; Fu X; Zhang R; Hovingh GK; Schimmel AW; Kastelein JJ; Stroes ES; Witztum JL; Hutten BA; Tsimikas S; Hazen SL; Chroni A; Kuivenhoven JA
    Arterioscler Thromb Vasc Biol; 2012 Dec; 32(12):3066-75. PubMed ID: 23023370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel homozygous frameshift mutation in the APOA1 gene associated with marked high-density lipoprotein deficiency.
    Takeda T; Ide T; Okuda D; Kuroda M; Asada S; Kirinashizawa M; Yamamoto M; Miyoshi J; Yokote K; Mizutani N
    J Clin Lipidol; 2022; 16(4):423-433. PubMed ID: 35778257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A unique genetic and biochemical presentation of fish-eye disease.
    Kuivenhoven JA; van Voorst tot Voorst EJ; Wiebusch H; Marcovina SM; Funke H; Assmann G; Pritchard PH; Kastelein JJ
    J Clin Invest; 1995 Dec; 96(6):2783-91. PubMed ID: 8675648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transmission of two novel mutations in a pedigree with familial lecithin:cholesterol acyltransferase deficiency: structure-function relationships and studies in a compound heterozygous proband.
    Argyropoulos G; Jenkins A; Klein RL; Lyons T; Wagenhorst B; St Armand J; Marcovina SM; Albers JJ; Pritchard PH; Garvey WT
    J Lipid Res; 1998 Sep; 39(9):1870-6. PubMed ID: 9741700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histopathology of corneal changes in lecithin-cholesterol acyltransferase deficiency.
    Viestenz A; Schlötzer-Schrehardt U; Hofmann-Rummelt C; Seitz B; Küchle M
    Cornea; 2002 Nov; 21(8):834-7. PubMed ID: 12410048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LCAT deficiency does not impair amyloid metabolism in APP/PS1 mice.
    Stukas S; Freeman L; Lee M; Wilkinson A; Ossoli A; Vaisman B; Demosky S; Chan J; Hirsch-Reinshagen V; Remaley AT; Wellington CL
    J Lipid Res; 2014 Aug; 55(8):1721-9. PubMed ID: 24950691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complete and Partial Lecithin:Cholesterol Acyltransferase Deficiency Is Differentially Associated With Atherosclerosis.
    Oldoni F; Baldassarre D; Castelnuovo S; Ossoli A; Amato M; van Capelleveen J; Hovingh GK; De Groot E; Bochem A; Simonelli S; Barbieri S; Veglia F; Franceschini G; Kuivenhoven JA; Holleboom AG; Calabresi L
    Circulation; 2018 Sep; 138(10):1000-1007. PubMed ID: 29748187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipoprotein X Causes Renal Disease in LCAT Deficiency.
    Ossoli A; Neufeld EB; Thacker SG; Vaisman B; Pryor M; Freeman LA; Brantner CA; Baranova I; Francone NO; Demosky SJ; Vitali C; Locatelli M; Abbate M; Zoja C; Franceschini G; Calabresi L; Remaley AT
    PLoS One; 2016; 11(2):e0150083. PubMed ID: 26919698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lecithin:cholesterol acyltransferase, high-density lipoproteins, and atheroprotection in humans.
    Calabresi L; Franceschini G
    Trends Cardiovasc Med; 2010 Feb; 20(2):50-3. PubMed ID: 20656215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A DNA polymorphism for LCAT is associated with altered LCAT activity and high density lipoprotein size distributions in baboons.
    Rainwater DL; Blangero J; Hixson JE; Birnbaum S; Mott GE; VandeBerg JL
    Arterioscler Thromb; 1992 Jun; 12(6):682-90. PubMed ID: 1350465
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Down-regulation of hepatic lecithin:cholesterol acyltransferase gene expression in chronic renal failure.
    Vaziri ND; Liang K; Parks JS
    Kidney Int; 2001 Jun; 59(6):2192-6. PubMed ID: 11380821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fractional efflux and net change in cellular cholesterol content mediated by sera from mice expressing both human apolipoprotein AI and human lecithin:cholesterol acyltransferase genes.
    Fournier N; Atger V; Paul JP; de la Llera Moya M; Rothblat G; Moatti N
    Atherosclerosis; 1999 Dec; 147(2):227-35. PubMed ID: 10559507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A first British case of fish-eye disease presenting at age 75 years: a double heterozygote for defined and new mutations affecting LCAT structure and expression.
    Winder AF; Owen JS; Pritchard PH; Lloyd-Jones D; Vallance DT; White P; Wray R
    J Clin Pathol; 1999 Mar; 52(3):228-30. PubMed ID: 10450185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apolipoprotein A-I in mouse cerebrospinal fluid derives from the liver and intestine via plasma high-density lipoproteins assembled by ABCA1 and LCAT.
    Tsujita M; Vaisman B; Chengyu L; Vickers KC; Okuhira KI; Braesch-Andersen S; Remaley AT
    FEBS Lett; 2021 Mar; 595(6):773-788. PubMed ID: 33020907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.